A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma

NCT03221348 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cho Pharma Inc.